Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Despite the FTC’s Objections, a Mega-Provider Healthcare System Could Be on the Horizon

Posted by Paul Darling on Wed, Aug 03, 2016

The current U.S. healthcare climate seems to produce a significant announcement each week of a hospital merger or acquisition. In fact, more than 100 provider mergers are anticipated for 2016. Amidst all of this M&A activity, the Federal Trade Commission (FTC) has been issuing and winning antitrust challenges for many of the larger provider M&As. Until recently, the FTC has been undefeated in all of the cases that it has challenged.

Read More

Topics: Pharmaceutical, m&a, Paul Darling, mergers, Advocate, commercial model, local healthcare market, providers, FTC, NorthShore

Adapting to the New Healthcare Ecosystem

Posted by Paul Darling on Wed, Feb 17, 2016

The evolution of U.S. healthcare gained pace and clarity as marked by some key events in 2015.  Specifically, more than 100 announced hospital mergers, three multibillion-dollar payer mergers, the successful defense of federal insurance subsidies in King v. Burwell, and the heated debate on drug prices point to an evolution with a clear direction that has important implications for life sciences companies.

Read More

Topics: healthcare ecosystem, Paul Darling, adapt, Pharmaceutical Executive, commercial model

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.